Todd Cooper, DO

• Acute Myeloid Leukemia

Todd M. Cooper, DO, is an attending physician at Seattle Children's, professor of pediatrics at the University of Washington School of Medicine and the Evans Family Endowed Chair in Pediatric Cancer. Dr. Cooper is the section head of Oncology and director of the Leukemia and Lymphoma Program.

Dr. Cooper's interests and expertise focus on the development of new therapeutic strategies for the treatment of acute leukemia in children. He initially helped develop Seattle Children’s High-Risk Leukemia Program and served as co-director of the program for eight years. Prior to coming to Seattle, Dr. Cooper developed and provided leadership for phase 1 developmental therapeutics programs at the University of Alabama at Birmingham and Children's Healthcare of Atlanta/Emory University. Dr. Cooper has led phase 1 studies of new agents for relapsed acute leukemia in a variety of national consortia including the Therapeutic Advances for Childhood Leukemia Consortium, Pediatric Oncology Experimental Therapeutics Investigator Consortium and the Children's Oncology Group (COG) Consortium.